How Much Does Target therapy for lung cancer Cost in Turkey in AUD?
| Turkey | Thailand | |
|---|---|---|
| Target therapy for lung cancer | from AUD $7,400 | ≈ AUD $13,400 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Target therapy for lung cancer upon arrival and use a flexible instalment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Target therapy for lung cancer and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Target therapy for lung cancer journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Target therapy for lung cancer Clinics in Turkey for Australians: 8 Verified Options and AUD Prices
Anadolu Medical Center
Seref Komurcu














Hisar Hospital Intercontinental
Mustafa Solak







Private Medicabil Hospital
Ozgur Taskapilioglu




Target therapy for lung cancer Overview in Turkey
- Lobectomy - from AUD $11,918The procedure involves removing a lung lobe, typically to treat conditions like lung cancer, improving patient health.
- Lung cancer surgery - from AUD $11,918The procedure removes tumors in the lungs, aids with diagnosis, and generally alleviates symptoms and prolongs life.
- Wedge Resection - from AUD $10,428This surgery removes a small, wedge-shaped part of lung tissue, primarily to treat localized lung cancer.
- Lung segmentectomy - from AUD $13,407This surgery removes lung segments harboring cancerous cells, protecting healthy tissue.
- Target therapy for lung cancer - from AUD $7,449This therapy specifically attacks cancer cells, reducing damage to healthy ones. It"s less severe with notable efficacy.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Trusted Doctors for Australian Patients
View all Doctors
Mustafa Solak
Dr. Solak specializes in lung cancer treatment with fellowship training at Hacettepe University Cancer Institute, one of Turkey's leading oncology centers.
- Trained at The University of Texas MD Anderson Cancer Center
- Experience with targeted therapies for various cancers including lung cancer
- Specializes in breast, ovarian, and gastrointestinal cancers as well
- Graduated from Hacettepe University – Turkey's top medical school

Eda Tanrıkulu Şimşek
Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.
- Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
- Participated in global training at Oxford University and ESMO in Manchester.
- Treats gastrointestinal, urological, lung, and breast cancers.
- Member of the American and European Societies of Medical Oncology.

Tahsin Ozatli
Specializes in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings targeted expertise to complex oncology cases at Istinye Liv University Hospital.
- Associate Professor since 2016
- Experience across multiple oncology departments in Turkey
- Trained at Selcuk University Faculty of Medicine

Cemil Bilir
Professor Cemil Bilir specializes in targeted therapies for lung cancer at VM Medical Park Pendik Hospital. His research includes advanced treatments at Northeastern University's Center for Pharmaceutical Biotechnology.
- Board-certified in medical oncology with 21 years of experience
- Member of ASCO and ESMO – stays updated on global oncology standards
- Academic professor training future oncologists at Sakarya University
- Research background in pharmaceutical biotechnology enhances treatment options
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Target therapy for lung cancer in Turkey
How effective is targeted therapy for lung cancer in Turkey?
Targeted therapy for lung cancer in Turkey is highly effective, especially for patients with genetic mutations like EGFR, ALK, or ROS1. Major Istanbul hospitals such as Anadolu Medical Center offer molecular testing and personalised treatments. Median progression-free survival reaches 12–19 months depending on mutation type.
- Mutation testing: Available at top clinics like Memorial Şişli and Anadolu Medical Center.
- EGFR-positive results: Median progression-free survival about 12.4 months.
- ALK-positive results: Alectinib therapy shows median survival near 30 months.
- Immunotherapy trials: Offered mainly for advanced non-small cell lung cancer.
- Leading oncologists: Doctors like Dr Eda Tanrikulu focus on personalised oncology.
Bookimed Expert Insight: Anadolu Medical Center and Memorial Şişli lead in targeted lung cancer care with recognised Joint Commission International (JCI) accreditation. Anadolu treats 65,000+ patients yearly with molecular diagnostics and immunotherapy. Many Turkish oncologists also participate in international clinical trials, giving patients access to new therapies.
Patient Consensus: Patients in Turkey praise targeted therapy for long-term cancer control and symptom relief. Many report stability and no cancer signs six months into treatment. Australian patients value thorough genetic testing and personalised treatment plans offered in Istanbul’s top centres.
How is the best targeted therapy for lung cancer chosen for me in Turkey?
The best targeted therapy for lung cancer in Turkey is chosen through detailed genetic testing of the tumour to find specific mutations like EGFR or ALK. Specialists at JCI-accredited hospitals such as Anadolu Medical Center tailor drug treatments based on these biomarkers and tumour type.
- Biomarker testing: Tumour tissue is analysed for mutations such as EGFR, ALK, KRAS, ROS1, and PD-L1.
- Multidisciplinary review: Oncologists, radiologists, and pathologists discuss test results and patient health.
- Advanced drugs: Tyrosine kinase inhibitors and monoclonal antibodies are matched to mutation profiles.
- Clinical trials: Access to bispecific antibodies (BNT327) and mRNA vaccines (BNT116) is available in Turkey.
- Follow-up testing: Repeat biopsies help adjust therapy if the cancer changes or progresses.
Bookimed Expert Insight: Clinics like Anadolu Medical Center in Istanbul offer personalised targeted therapies backed by biomarker tests and global trials. Many top oncologists lead international studies, so clinical trial options are a key advantage in Turkey’s treatment landscape.
Patient Consensus: Patients value the thorough testing and personalised approach in Turkey. Many recommend doing full biomarker panels early and appreciate the option of innovative drug therapies and clinical trials alongside standard treatments.
What are the common side effects of targeted therapy for lung cancer treatment in Turkey?
Common side effects of targeted therapy for lung cancer in Turkey include skin rashes, fatigue, diarrhoea, liver enzyme changes, and muscle or joint pain. Treatments like Osimertinib deliver effective results with generally manageable side effects monitored by experienced oncologists at JCI-accredited centres like Anadolu Medical Center.
- Skin reactions: acne-like rash on face, dryness causing fingertip cracks.
- Fatigue: patients often feel tired, sometimes for weeks.
- Gastrointestinal issues: diarrhoea, nausea, vomiting, and loss of appetite.
- Liver monitoring: some drugs may raise liver enzymes, needing checks.
- Other effects: muscle/joint pain, occasional vision changes, swelling in limbs.
Bookimed Expert Insight: Turkish hospitals like Anadolu Medical Center offer tailored therapy based on tumour genetics, improving tolerance and reducing side effects. Oncologists such as Dr Eda Tanrikulu focus on precise mutation targeting, helping patients avoid severe effects common elsewhere. Monitoring protocols in JCI-accredited facilities ensure side effects stay manageable.
Patient Consensus: Patients in Turkey report side effects vary by drug but often include hair thinning and skin changes like mild burns. Most feel fatigue but find it manageable with good doctor support. Despite some nausea and appetite changes, patients appreciate thorough monitoring and clear symptom management.
Is targeted therapy suitable for all lung cancer types when treated in Turkey?
Targeted therapy in Turkey is suitable mainly for non-small cell lung cancer (NSCLC) patients with specific genetic mutations. It focuses on tumours with alterations like EGFR, ALK, or BRAF. Small cell lung cancer (SCLC) generally requires chemotherapy or immunotherapy instead.
- Genetic testing: Required to identify specific mutations before therapy.
- Primary candidates: NSCLC patients with EGFR+, ALK+, or BRAF+ mutations.
- Small cell lung cancer: Usually treated with chemo or immunotherapy, not targeted therapy.
- Clinical trials: Turkey offers options like bispecific antibodies for NSCLC.
- Mutation coverage: Confirm if mutations match therapies available at Turkish centres.
Bookimed Expert Insight: Most leading Turkish oncology centres, such as Anadolu Medical Center and Hisar Hospital, tailor therapy strictly to genetic profiles. Clinics often combine molecular testing with access to international clinical trials, providing therapies unavailable elsewhere. Australian patients benefit by bringing biomarker reports to speed up treatment plans.
Patient Consensus: Many patients found genetic testing crucial before targeted therapy in Turkey. NSCLC patients especially praise quick access to tailored treatments and advanced trials. SCLC patients often appreciate clear advice on alternative therapies like immunotherapy.
Do I need to be in Turkey for the entire duration of targeted therapy for lung cancer?
Patients generally do not need to stay in Turkey for the entire duration of targeted therapy for lung cancer. Initial visits for diagnosis, genetic testing, and treatment setup typically last 7–10 days. After this, treatment is often managed remotely with regular follow-ups and scans.
- Initial stay: About 7–10 days for diagnosis and starting therapy.
- Follow-up: Periodic scans and consultations usually require brief returns.
- Treatment form: Targeted therapy is mostly oral medication taken at home.
- Clinical trials: Continuous presence in Turkey may be needed for strict protocols.
- Remote support: Some Istanbul clinics offer telehealth for Australians abroad.
Bookimed Expert Insight: Most patients find flexible treatment schedules benefit long-term stability. Clinics like Anadolu Medical Center have personal coordinators and remote follow-up, easing travel constraints for Australians. Clinical trial participants have stricter on-site requirements, so checking therapy type matters.
Patient Consensus: Patients in Turkey report the initial hospital stay is short. Many continue therapy back home, travelling for scans or appointments. Those on trials stay longer due to treatment monitoring.
How is targeted therapy for lung cancer administered in Turkey?
Targeted therapy for lung cancer in Turkey is given either as daily oral pills or intravenous infusions at hospitals. Treatment is personalised based on genetic testing for mutations like EGFR. Leading hospitals such as Memorial Şişli and Anadolu Medical Center use biomarker-driven protocols and offer ongoing monitoring with blood tests and scans.
- Administration methods: oral pills taken at home or intravenous infusions at outpatient clinics.
- Molecular testing: essential to identify genetic mutations before therapy starts.
- Combination options: targeted therapy may be used alongside chemotherapy or immunotherapy.
- Patient monitoring: regular blood tests and imaging track treatment success and side effects.
- Clinical trials: Turkey offers access to therapies like bispecific antibodies and mRNA vaccines.
Bookimed Expert Insight: Clinics with Joint Commission International (JCI) accreditation, like Memorial Şişli Hospital, maintain strict quality and safety. Hospitals like Anadolu Medical Center combine personalised care with international clinical trials. Patients benefit most when biomarker testing is completed before travel to avoid delays.
Patient Consensus: Patients highlight the importance of full gene testing before arriving. Many note flexibility with oral treatments at home, while infusions are provided with good hospital support. Turkish hospitals follow European standards, making targeted therapy accessible and well managed.
Does Turkey offer access to new or trial targeted therapy medications for lung cancer?
Turkey offers access to new and trial targeted therapies for lung cancer via clinical trials and personalised treatments. Leading hospitals like Anadolu Medical Center and Hisar Hospital Intercontinental provide therapies including bispecific antibodies, mRNA vaccines, and protein inhibitors. Treatments often match tumour genetic profiles.
- Clinical trials: Active phase II/III trials include bispecific antibodies and mRNA lung cancer vaccines.
- Key hospitals: Anadolu Medical Center (Istanbul) and hospitals in Ankara and Istanbul run these trials.
- Targeted drugs: Access to medications like Gilotrif, Tagrisso, and Tarceva is available in Turkey.
- Eligibility: Trial entry depends on mutation status, disease stage, and strict medical criteria.
- Immunotherapy: Widely used for advanced lung cancer when trials are not an option.
Bookimed Expert Insight: Trial availability in Turkey is tightly linked to leading oncology centres like Anadolu Medical Center, which serves 65,000+ patients yearly and leads research in targeted therapies. Many doctors here participate in global clinical trials, giving patients access to treatments unavailable outside trials. This high patient volume and active research boost trial openings but require early planning due to eligibility limits.
Patient Consensus: Patients in Turkey appreciate the chance to join experimental lung cancer trials, noting strong support from hospital teams. Many highlight personalised therapies based on genetic testing and report stability on immunotherapy where trials aren’t accessible. Trial sites mostly concentrate in Istanbul and Ankara, offering practical options for Australians flying in.













